Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, M. F.
Right arrow Articles by Haralabatos, I. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, M. F.
Right arrow Articles by Haralabatos, I. C.
(Chest. 2001;119:1001-1010.)
© 2001 American College of Chest Physicians

Comparisons of Peak Diurnal Expiratory Flow Variation, Postbronchodilator FEV1 Responses, and Methacholine Inhalation Challenges in the Evaluation of Suspected Asthma*

Marc F. Goldstein, MD, FCCP; Bernadette A. Veza, MBS; Eliot H. Dunsky, MD; Donald J. Dvorin, MD; George A. Belecanech, MD and Irene C. Haralabatos, MD

* From the Department of Medicine and Pediatrics (Drs. Goldstein, Dunsky, Dvorin, Belecanech, and Haralabatos), Allergy and Immunology Division, and the Interdepartmental Medical Science Program (Ms. Veza); MCP Hahnemann University, Philadelphia, PA.

Correspondence to: Marc F. Goldstein, MD, FCCP, Professional Arts Building, Suite 300, 205 N. Broad St, Philadelphia, PA 19107; e-mail: gpike35{at}aol.com

Study objectives: The validity of peak expiratory flow variation (PEFvar) as defined by National Heart, Lung, and Blood Institute (NHLBI) guidelines as a diagnostic tool for suspected asthma or its comparative value to methacholine inhalation challenge (MIC) or postbronchodilator (BD) FEV1 responses has not been formally assessed. We prospectively analyzed the correlation of 28 different PEFvar indexes (including 4 NHLBI-compatible indexes) with MIC and pre-BD and post-BD FEV1 responses in suspected asthmatic subjects with normal findings on lung examination, chest radiography, and baseline spirometry.

Design: Participants were asked to record peak expiratory flow four times daily for 2 to 3 weeks, followed by an MIC. During a minimum 6-month follow-up period, a clinical diagnosis of asthma was made or ruled out based on testing results and response to antiasthma therapy.

Setting: Medical school-affiliated subspecialty private practice of allergy, asthma, and immunology.

Participants: One hundred twenty-one suspected asthmatic patients with normal findings on lung examination, chest radiography, and baseline spirometry.

Measurements and results: Fifty-seven subjects completed both the peak flow diary and the MIC and were accepted for statistical analysis. There were no statistically significant correlations between any peak expiratory flow index and MIC. Among the three diagnostic tools evaluated, MIC had the highest sensitivity (85.71%). All the PEFvar indexes and post-BD responses had low sensitivity and high false-negative rates.

Conclusions: PEFvar and post-BD FEV1 responses are poor substitutes for MIC in the assessment of patients with suspected asthma with normal findings on lung examination, chest radiography, and spirometry. Our findings warrant a reconsideration of the NHLBI guidelines recommendation of the utility of PEFvar as a diagnostic tool for asthma in clinical practice.

Key Words: diurnal variation • methacholine challenge • peak expiratory flow variation • postbronchodilator FEV1 responses




This article has been cited by other articles:


Home page
ChestHome page
H. Kang, Y. Y. Koh, Y. Yoo, J. Yu, D. K. Kim, and C. K. Kim
Maximal Airway Response to Methacholine in Cough-Variant Asthma: Comparison With Classic Asthma and Its Relationship to Peak Expiratory Flow Variability
Chest, December 1, 2005; 128(6): 3881 - 3887.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. D. Smith, J. O. Cowan, S. Filsell, C. McLachlan, G. Monti-Sheehan, P. Jackson, and D. R. Taylor
Diagnosing Asthma: Comparisons between Exhaled Nitric Oxide Measurements and Conventional Tests
Am. J. Respir. Crit. Care Med., February 15, 2004; 169(4): 473 - 478.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
V. Bellia, F. Pistelli, D. Giannini, N. Scichilone, F. Catalano, M. Spatafora, R. Hopps, L. Carrozzi, S. Baldacci, F. Di Pede, et al.
Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients
Eur. Respir. J., May 1, 2003; 21(40_suppl): 21S - 27s.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. J. Dupont, M. G. Demedts, and G. M. Verleden
Prospective Evaluation of the Validity of Exhaled Nitric Oxide for the Diagnosis of Asthma
Chest, March 1, 2003; 123(3): 751 - 756.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Chest Physicians.